rhIGF-1/rhIGFBP-3

TERMINATED · PHASE2 · Noonan Syndrome

Terminated due to a patent legal settlement

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.